Overview
Hydrocephalus with stenosis of the aqueduct of Sylvius (also known as aqueductal stenosis or X-linked hydrocephalus when caused by L1CAM mutations) is a congenital condition in which the cerebral aqueduct (aqueduct of Sylvius), a narrow channel connecting the third and fourth ventricles of the brain, is abnormally narrowed or blocked. This obstruction prevents the normal flow of cerebrospinal fluid (CSF), leading to its accumulation within the ventricles and resulting in hydrocephalus — an enlargement of the fluid-filled spaces in the brain. The condition primarily affects the central nervous system and can cause increased intracranial pressure, progressive enlargement of the head (macrocephaly), and damage to surrounding brain tissue. Key clinical features include macrocephaly, bulging fontanelles in infants, developmental delay, intellectual disability, spasticity (particularly of the lower limbs), and adducted (clasped) thumbs — the latter being especially characteristic of the X-linked form caused by mutations in the L1CAM gene (Xq28). This X-linked recessive form, also known as HSAS (Hydrocephalus due to Stenosis of the Aqueduct of Sylvius) or Bickers-Adams syndrome, predominantly affects males. However, aqueductal stenosis can also occur sporadically or as part of other genetic syndromes, and non-genetic causes such as infections or hemorrhage may also contribute. Treatment is primarily surgical and involves placement of a ventriculoperitoneal (VP) shunt to divert excess CSF from the brain ventricles to the abdominal cavity, thereby reducing intracranial pressure. Endoscopic third ventriculostomy (ETV) is an alternative surgical approach in selected patients. Early intervention is critical to minimize brain damage. Supportive therapies including physical therapy, occupational therapy, and developmental support are important components of long-term management. Despite treatment, many affected individuals experience some degree of intellectual disability and neurological impairment, and the prognosis varies depending on the severity and underlying cause.
Also known as:
Clinical phenotype terms— hover any for plain English:
X-linked recessive
Carried on the X chromosome; typically affects males more than females
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Hydrocephalus with stenosis of the aqueduct of Sylvius.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hydrocephalus with stenosis of the aqueduct of Sylvius at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Hydrocephalus with stenosis of the aqueduct of Sylvius.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesRaloxifene Hydrochloride
NorthStar Rx LLC
Raloxifene Hydrochloride — Contact NorthStar Rx LLC
Travel Grants
No travel grants are currently matched to Hydrocephalus with stenosis of the aqueduct of Sylvius.
Community
No community posts yet. Be the first to share your experience with Hydrocephalus with stenosis of the aqueduct of Sylvius.
Start the conversation →Latest news about Hydrocephalus with stenosis of the aqueduct of Sylvius
No recent news articles for Hydrocephalus with stenosis of the aqueduct of Sylvius.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hydrocephalus with stenosis of the aqueduct of Sylvius
What is Hydrocephalus with stenosis of the aqueduct of Sylvius?
Hydrocephalus with stenosis of the aqueduct of Sylvius (also known as aqueductal stenosis or X-linked hydrocephalus when caused by L1CAM mutations) is a congenital condition in which the cerebral aqueduct (aqueduct of Sylvius), a narrow channel connecting the third and fourth ventricles of the brain, is abnormally narrowed or blocked. This obstruction prevents the normal flow of cerebrospinal fluid (CSF), leading to its accumulation within the ventricles and resulting in hydrocephalus — an enlargement of the fluid-filled spaces in the brain. The condition primarily affects the central nervous
How is Hydrocephalus with stenosis of the aqueduct of Sylvius inherited?
Hydrocephalus with stenosis of the aqueduct of Sylvius follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Hydrocephalus with stenosis of the aqueduct of Sylvius typically begin?
Typical onset of Hydrocephalus with stenosis of the aqueduct of Sylvius is neonatal. Age of onset can vary across affected individuals.
What treatment and support options exist for Hydrocephalus with stenosis of the aqueduct of Sylvius?
1 patient support program are currently tracked on UniteRare for Hydrocephalus with stenosis of the aqueduct of Sylvius. See the treatments and support programs sections for copay assistance, eligibility, and contact details.